Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to 0.47.

  • Xtant Medical Holdings' Equity Ratio rose 247.75% to 0.47 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.47, marking a year-over-year increase of 247.75%. This contributed to the annual value of 0.46 for FY2024, which is 1742.36% down from last year.
  • Latest data reveals that Xtant Medical Holdings reported Equity Ratio of 0.47 as of Q3 2025, which was up 247.75% from 0.47 recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Equity Ratio ranged from a high of 0.59 in Q3 2023 and a low of 0.46 during Q4 2024
  • For the 5-year period, Xtant Medical Holdings' Equity Ratio averaged around 0.52, with its median value being 0.53 (2022).
  • Within the past 5 years, the most significant YoY rise in Xtant Medical Holdings' Equity Ratio was 15204.38% (2021), while the steepest drop was 4831.3% (2021).
  • Xtant Medical Holdings' Equity Ratio (Quarter) stood at 0.56 in 2021, then grew by 0.47% to 0.57 in 2022, then decreased by 2.27% to 0.55 in 2023, then fell by 17.42% to 0.46 in 2024, then increased by 3.5% to 0.47 in 2025.
  • Its Equity Ratio stands at 0.47 for Q3 2025, versus 0.47 for Q2 2025 and 0.46 for Q1 2025.